MedTrace Logo

Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer

NCT00540280 · Status: SUSPENDED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2011-03-08

No results posted yet for this study

Summary

Randomized Phase III trial of surgery alone or surgery plus preoperative Gemcitabine-Cisplatin in clinical early stages of non-small cell lung cancer

Conditions

  • Carcinoma, Non-Small-Cell Lung

Interventions

RADIATION

Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin

Surgery + Chemo + RT

Sponsors & Collaborators

  • King Faisal Specialist Hospital & Research Center

    lead OTHER

Principal Investigators

  • Khalid Rehman, MD · King Faisal Specialist Hospital & Research Centre, Saudi Arabia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2003-10-31
Completion
2013-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00540280 on ClinicalTrials.gov